Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104.Phillip McCarthy, Kouros Owzar, K. C. Anderson et al.|Journal of Clinical Oncology|2010Cited by 82